- Home
- SVA vs LPLA Comparison
SVA vs LPLA Comparison
Compare SVA & LPLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- LPLA
- Stock Information
- Founded
- SVA N/A
- LPLA 1989
- Country
- SVA
- LPLA United States
- Employees
- SVA 3261
- LPLA N/A
- Industry
- SVA
- LPLA Investment Bankers/Brokers/Service
- Sector
- SVA
- LPLA Finance
- Exchange
- SVA NYSE
- LPLA Nasdaq
- Market Cap
- SVA N/A
- LPLA 15.8B
- IPO Year
- SVA N/A
- LPLA 2010
- Fundamental
- Price
- SVA $6.47
- LPLA $256.08
- Analyst Decision
- SVA
- LPLA Buy
- Analyst Count
- SVA 0
- LPLA 15
- Target Price
- SVA N/A
- LPLA $276.86
- AVG Volume (30 Days)
- SVA N/A
- LPLA 858.9K
- Earning Date
- SVA N/A
- LPLA 10-30-2024
- Dividend Yield
- SVA N/A
- LPLA 0.47%
- EPS Growth
- SVA N/A
- LPLA N/A
- EPS
- SVA N/A
- LPLA 12.80
- Revenue
- SVA N/A
- LPLA $10,930,574,000.00
- Revenue This Year
- SVA N/A
- LPLA $20.61
- Revenue Next Year
- SVA N/A
- LPLA $16.64
- P/E Ratio
- SVA N/A
- LPLA $20.01
- Revenue Growth
- SVA N/A
- LPLA 16.49
- 52 Week Low
- SVA N/A
- LPLA $187.19
- 52 Week High
- SVA N/A
- LPLA $289.88
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- LPLA 68.14
- Support Level
- SVA N/A
- LPLA $254.31
- Resistance Level
- SVA N/A
- LPLA $263.45
- Average True Range (ATR)
- SVA 0.00
- LPLA 5.52
- MACD
- SVA 0.00
- LPLA 1.09
- Stochastic Oscillator
- SVA 0.00
- LPLA 78.48
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About LPLA LPL Financial Holdings Inc.
LPL Financial Holdings is an independent broker/dealer that provides a platform of proprietary technology, brokerage, and investment advisory services to financial advisors and institutions. As of the end of 2023, the company had over 20,000 advisors on its platform managing over $1.3 trillion of client assets.